C4 Therapeutics Aktie
WKN DE: A2QC0X / ISIN: US12529R1077
|
12.12.2023 13:24:36
|
C4 Therapeutics, Merck Join To Develop Degrader-Antibody Conjugates
(RTTNews) - C4 Therapeutics, Inc. (CCCC) has entered into an exclusive license and collaboration agreement with Merck to develop degrader-antibody conjugates, an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells. C4T will be responsible for using its TORPEDO platform to develop degrader payloads in the discovery phase. Merck will be responsible for antibody conjugation to create DACs in the discovery phase and for advancing these DAC candidates through preclinical and clinical development as well as commercialization.
C4T will receive a $10 million upfront payment. C4T and Merck will collaborate to develop Degrader-Antibody Conjugates directed to an initial undisclosed oncology target. For Degrader-Antibody Conjugates directed to this initial target, C4T is eligible to receive milestone payments totaling approximately $600 million, as well as tiered royalties on future sales.
The agreement also provides Merck with the option to extend the collaboration to include three additional targets.
For More Such Health News, visit rttnews.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck Co.mehr Nachrichten
|
17.09.25 |
Zuversicht in New York: Dow Jones verbucht zum Handelsende Gewinne (finanzen.at) | |
|
17.09.25 |
Freundlicher Handel in New York: Dow Jones-Anleger greifen zu (finanzen.at) | |
|
17.09.25 |
Handel in New York: Dow Jones am Mittwochmittag in der Gewinnzone (finanzen.at) | |
|
17.09.25 |
Dow Jones aktuell: Dow Jones zum Handelsstart mit Zuschlägen (finanzen.at) | |
|
16.09.25 |
Börse New York in Rot: Dow Jones sackt zum Ende des Dienstagshandels ab (finanzen.at) | |
|
16.09.25 |
Dow Jones-Handel aktuell: Dow Jones liegt am Dienstagnachmittag im Minus (finanzen.at) | |
|
16.09.25 |
Börse New York: So entwickelt sich der Dow Jones am Dienstagmittag (finanzen.at) | |
|
16.09.25 |
Angespannte Stimmung in New York: Dow Jones zum Handelsstart im Minus (finanzen.at) |
Analysen zu Merck Co.mehr Analysen
Aktien in diesem Artikel
| C4 Therapeutics Inc Registered Shs | 3,38 | -0,88% |
|
| Merck Co. | 69,00 | -0,29% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.